• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Neurofilament-light – Update from EAN

July 14, 2020  

Update on B cells in MS pathophysiology

June 29, 2020  

Cognitive dysfunction in MS: Update from EAN

June 10, 2020  

SPMS: new data and developments

June 2, 2020  

Sun exposure and MS: effects beyond vitamin D

May 26, 2020  

Treatment optimization in MS – new Canadian recommendations

May 15, 2020  

Siponimod – new data in SPMS

April 23, 2020  

FDA approves ozanimod in MS

April 16, 2020  

MS and coronavirus have a long history

April 9, 2020  

MS 2020 – the view from a decade ago

March 18, 2020  
Previous
19
20
21
22
23
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
  • High-efficacy DMTs for MS: the year in review posted on December 1, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions